Rhumbline Advisers PREVAIL THERAPEUTICS IN Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021
SELL
N/A
-15,258 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
N/A
1,050 Added 7.39%
15,258 $352,000
Q3 2020

Nov 12, 2020
SELL
N/A
-808 Reduced 5.38%
14,208 $145,000
Q2 2020

Aug 13, 2020
BUY
N/A
15,016 New
15,016 $224,000
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email